Last reviewed · How we verify
Nitrous Oxide/Oxygen — Competitive Intelligence Brief
marketed
Inhalational anesthetic and analgesic gas
NMDA receptor antagonist; GABAergic potentiator
Anesthesia and Sedation
Small molecule
Live · refreshed every 30 min
Target snapshot
Nitrous Oxide/Oxygen (Nitrous Oxide/Oxygen) — Nationwide Children's Hospital. Nitrous oxide acts as a dissociative anesthetic and analgesic by modulating NMDA receptor activity and enhancing inhibitory neurotransmission in the central nervous system.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Nitrous Oxide/Oxygen TARGET | Nitrous Oxide/Oxygen | Nationwide Children's Hospital | marketed | Inhalational anesthetic and analgesic gas | NMDA receptor antagonist; GABAergic potentiator |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (Inhalational anesthetic and analgesic gas class)
- Nationwide Children's Hospital · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Nitrous Oxide/Oxygen CI watch — RSS
- Nitrous Oxide/Oxygen CI watch — Atom
- Nitrous Oxide/Oxygen CI watch — JSON
- Nitrous Oxide/Oxygen alone — RSS
- Whole Inhalational anesthetic and analgesic gas class — RSS
Cite this brief
Drug Landscape (2026). Nitrous Oxide/Oxygen — Competitive Intelligence Brief. https://druglandscape.com/ci/nitrous-oxide-oxygen. Accessed 2026-05-14.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab